1.Rep78/68 protein of adeno-associated virus
Basic & Clinical Medicine 2006;0(09):-
Rep78/68 is a kind of nonstructural protein from adeno-associated virus. It inhibits a variety of viruses and tumor transformation. In addition, it has significant effect on the proliferation and metabolism of host cells. In this paper, we reviewed the latest research advances of this protein.
2.More studies on diagnostic pathology of liver diseases.
Tai-ling WANG ; Xia LIU ; Hong YOU
Chinese Journal of Hepatology 2007;15(5):321-322
4.Application Evaluation of Clinical Pathway-based Teaching Methods in Clinical Teaching of Hematology
Zeping ZHOU ; Hong YANG ; Yuebo LIU ; Lin LIU ; You ZHANG
Journal of Kunming Medical University 2014;(1):152-154
Objective To investigate the effects of clinical pathway-based teaching methods in clinical teaching of hematology. Methods Interns, which studied in department of hematology, were classified non-randomized into two groups. The interns in experimental group received idiopathic thrombocytopenic purpura (ITP) clinical pathway-based teaching. And the interns in the control group received the seventh edition textbook of medicine-based traditional teaching. All interns were oral tested when they finished two weeks period clinical studied of hematology. Meanwhile, a questionnaire designed for clinical pathway-based teaching was included in this test only for the experimental group. Results There were 32 interns recruited in the group of clinical pathway-based teaching and 38 interns in the control group of traditional teaching. There were statistically significant differences between the two groups in the fields of the key points about history of diseases ( = 0.0017), assessment of diagnostic criteria and differential diagnosis ( =0.0074), selection of laboratory examination items ( <0.0001) for ITP. The group of clinical pathway-based teaching achieved higher scores than the control group. However, there was no statistically significant difference between the two groups in the field of selection of first-line treatment measure of ITP ( = 0.1155) . Moreover, the control group achieved higher scores than the group of clinical pathway-based teaching in the field of how to treat ITP patients with first-line treatment failure ( =0.0003) . In addition,there were 93.8%interns in the experimental group accepted the new clinical pathway-based teaching tool in the survey. The open-ended question survey showed the clinical pathway teaching method was more simple, intuitive and standardizing than the traditional one. Conclusion The ITP clinical pathway, as an interns teaching tool of hematology, is helpful for understanding more clearly the diagnosis and treatment of ITP. However, an in-depth explanation is necessary combination with textbook of medicine study in the clinical teaching of ITP.
5.Intelligent Rotational Behavior Monitor for Experiment Animal
Xin LIU ; You WU ; Yan WANG ; Hong SHA
Chinese Journal of Comparative Medicine 2009;19(3):64-68
Objective to develop a rotation monitoring device to monitor animal rotation during experiments.Methods Use serial port controls,USB and rotary encoder et al.modern computer cience,with the combination of traditionally experimental methods and the software designed in VC language.Results A mini animal rotation monitor was developed,which could continuously monitor animal rotation and intelligently display the rotaion.conclusion Statistic analysis of experimental data proofs the rationality and effectiveness of the apparatus.The rotational behavior monitor can play an importance role in research into the pathogenesis of Parkinson's Disease(PD)and screening the anti-PD drugs.
6.Inhibitive effect of troglitazone on TGF-beta(1) and fibronectin expression in human peritoneal mesothelial cells.
Hong LIU ; You-ming PENG ; Fu-you LIU ; Ying-hong LIU ; Ling-yan LI ; Jun LI ; Xing CHEN
Journal of Central South University(Medical Sciences) 2007;32(3):473-479
OBJECTIVE:
To investigate the effect of the peroxisome proliferator activated receptor-gamma (PPAR-gamma) agonist troglitazone on TGF-beta(1) and fibronectin (Fn) expression in human peritoneal mesothelial cells (HPMCs).
METHODS:
HPMCs were cultured from human omentum by an enzyme digestion method, growing in medium containing 30 mmol/L D-glucose. TGF-beta(1) and Fn expression were measured in HPMCs in the presence and absence of 15 micromol/L troglitazone. The mRNA expressions of PPAR-gamma,TGF-beta(1) and Fn were determined by semi-quantification reverse transcriptive PCR (RT-PCR). The protein of TGF-beta(1) was determined by enzyme-linked immunosorbent assay (ELISA) and proteins of PPAR-gamma and Fn were determined by Western blot.
RESULTS:
The mRNA and protein expression of TGF-beta(1) and Fn were significantly increased in HPMCs stimulated with 30 mmol/L D-glucose compared with the control group with F12 media (P<0.01). Obvious decrease of TGF-beta(1) was found in troglitazone(15 micromol/L) treated group compared with group stimulated with 30 mmol/L D-glucose (P<0.05). Exposure of HPMCs to troglitazone reduced the Fn secretion (P<0.05).
CONCLUSION
Troglitazone reduced the expression of TGF-beta(1) in HPMCs stimulated by 30mmol/L D-glucose, and reduced Fn production. PPAR-gamma agonists may have a specific role in ameliorating the course of progressive peritoneal fibrosis under long-term peritoneal dialysis states.
Blotting, Western
;
Cells, Cultured
;
Chromans
;
pharmacology
;
Dose-Response Relationship, Drug
;
Enzyme-Linked Immunosorbent Assay
;
Epithelial Cells
;
cytology
;
drug effects
;
metabolism
;
Fibronectins
;
biosynthesis
;
genetics
;
Glucose
;
pharmacology
;
Humans
;
PPAR gamma
;
biosynthesis
;
genetics
;
Peritoneum
;
cytology
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Thiazolidinediones
;
pharmacology
;
Transforming Growth Factor beta1
;
biosynthesis
;
genetics
;
Troglitazone
7.Recent advances in the structure-activity relationship study of small-molecule sodium channel blockers with analgesic effects.
Wen LI ; You ZHOU ; Hong-Min LIU ; Qi-Dong YOU
Acta Pharmaceutica Sinica 2009;44(2):101-108
Pain is one of the common clinical symptom, previous studies have implicated sodium channels as a key constituent in pain signaling. Sodium channel blockers with efficient sodium channel blockade effect play an important role in analgesic treatment. However, most drugs used in clinic have many drawbacks and can not meet the demand of the clinical use. Therefore, for the development of new generation of sodium channel blockers, it is of great significance to find small molecule sodium channel blocking lead compounds with novel chemical scaffolds and new structures, sodium channel blocking activity and structure-activity relationship are discussed in detail, and current problems and trends in future research are also emphasized.
Analgesics
;
chemistry
;
pharmacology
;
therapeutic use
;
Animals
;
Drug Design
;
Humans
;
Molecular Structure
;
Neuralgia
;
drug therapy
;
Pain
;
drug therapy
;
Pain Measurement
;
Sodium Channel Blockers
;
chemistry
;
pharmacology
;
therapeutic use
;
Sodium Channels
;
drug effects
;
Structure-Activity Relationship
8.Construction and identification of eukaryotic expressing vector for multiple myeloma MUC1-2VNTR
Yunjiao LUO ; Kun LIU ; Yuebo LIU ; Hong YANG ; Jin YAO ; Liang SHAO ; You ZHANG
Journal of Leukemia & Lymphoma 2008;17(5):334-336
Objective To construct multiple myeloma mucin MUC1-2VNTR gene eukaryotic expressing vector,which provided the basic material for further study of multiple myeloma DNA vaccine.Methods MUC1-2VNTR coding gene as target gene,and a KOZAK sequence was inserted before it.Hind Ⅲ and Xba Ⅰ restriction enzyme site were inserted on both ends.Then the whole sequence was synthesized and cloned into pcDNA3.1/myc-his B vector,and the recombinant vector was identified by restriction enzyme digestion and DNA sequencing.Results Synthesized MUC1-2VNTR gene was 140 bp.Restriction enzyme digestion and DNA sequencing confirmed pcDNA3.1/MUC1-2VNTR/myc-his B including the whole exact translation frame region and MUC1-2VNTR gene.Condnsion The pcDNA3.1/MUC1-2VNTR/myc-his B has been successfully constructed,which provides the basic material for further studies of MUC1 mucin function and multiple myloma DNA vaccine.
9.Inhibition of Nuclear Factor-?B Activity by Mesenchymal Stem Cells in Rats with Myocardial Infarction
You-You DU ; Sheng-Hua ZHOU ; Tao ZHOU ; Qi-Ming LIU ; Hua SU ; Hong-Wei PAN ; Bin LIU ; Wan-Hong DU ;
Chinese Journal of Hypertension 2007;0(06):-
Objective To investigate the effect of mesenchymal stem cells (MSC) on the activity of nuclear factor (NF)-?B in rats with myocardial infarction.Methods MSC were isolated from SD rats (120—150 g in weight).SD rats (180—200 g in weight) were subjected to MI by left coronary artery occlusion,and were allo- cated into three groups randomly:1)sham group (without ligation of the artery,n=8);2)injection of PBS solu- tion (n=8);3)injection of MSC (n=8).MSC or PBS solution was injected into myocardium from epicardium instantly after MI models were established.Four weeks after transplantation,cardiac function was evaluated u- sing physiological recorder.Western blot were performed to investigate the nuclear factor-? activity.The ex- pressions of tumor necrosis factor (TNF)-? and interleukin (IL)-6 were evaluated by RT-PCR and Western blot. Results 1)Mortality was 20%(2/10) in sham group,33.3%(4/12) in PBS group and 20%(2/10) in MSC group with no statistic differences between them(P=0.646).2) Hemodynamic measurements showed that MSC trans- plantation caused significant improvement in cardiac function,comparing with MI+PBS group.3) MSC inhibi- ted the activities of NF-?B in myocardium and down-regulated the expression of TNF-? and IL-6 in mRNA and protein level.Conclusion Transplantation of MSC improved cardiac function in MI rats,which may partly at- tribute to their immuno-inflammatory regulation mechanism.
10.Role of endothelin-1 and its receptors on hypertrophy or proliferation of cultured cardial cells.
Hong-Wen YOU ; Xi CHEN ; Hong-Jie YOU ; Yu-Qing ZHANG ; Yan CAI ; Guo-Zhang LIU
Acta Academiae Medicinae Sinicae 2006;28(4):520-523
OBJECTIVETo investigate the role of endothelin-1 and its receptors on hypertrophy or proliferation of cultured cardial cells.
METHODSCardiomyocytes and cardiac fibroblasts were isolated by trypsin digestion method, DNA and protein synthesis were measured by 3H-dexyribonucleotidethymine (3H-TdR) and 3H-Leucine (3H-Leu) incorporation, while protein content was measured by Bradford method. Atrial natriuretic peptide (ANP) mRNA expression of cardiomyocyte was measured by reverse transcripted-polymerase chain reaction. Selective endothelin (ET) receptor subtype antagonists BQ123 and BQ788 were used to block ET(A) receptors (ET(A)R) and ET(B)R respectively and to observe the effects of the two receptors during cardiac hypertrophy.
RESULTSET-1 significantly increased the 3H-TdR and 3H-Leu incorporation rate of cardiomyocytes and cardiac fibroblasts in a dose-dependent manner and increased protein content. Furthermore, ET-1 promoted the ANP mRNA expression of cardiomyocyte. ET(A)R antagonist remarkably blocked these effects, while ET(B)R antagonist had no obvious effect.
CONCLUSIONSET-1 can induce the hypertrophy for cardiomyocytes and the proliferation for cardiac fibroblasts. These effects are mediated by ET(A)R.
Animals ; Animals, Newborn ; Atrial Natriuretic Factor ; biosynthesis ; genetics ; Cell Proliferation ; Cells, Cultured ; Endothelin-1 ; physiology ; Fibroblasts ; cytology ; pathology ; Hypertrophy ; Myocytes, Cardiac ; cytology ; pathology ; RNA, Messenger ; biosynthesis ; genetics ; Rats ; Rats, Sprague-Dawley ; Receptor, Endothelin A ; physiology